Innoviva (INVA) Net Income towards Common Stockholders Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -58.11% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -95.76% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -290.15% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 59.59% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -129.68% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -10.08% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1,228.66% |
| 10 | Innoviva | 1.60 Bn | 992.84 Mn | 75.83 Mn | 500.44% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 500.44% |
| Dec 31, 2025 | -31.16% |
| Sep 30, 2025 | 7,312.78% |
| Jun 30, 2025 | 283.62% |
| Mar 31, 2025 | -227.56% |
| Dec 31, 2024 | -60.22% |
| Sep 30, 2024 | -98.52% |
| Jun 30, 2024 | -2,809.77% |
| Mar 31, 2024 | 4.76% |
| Dec 31, 2023 | 36.31% |
| Sep 30, 2023 | -69.10% |
| Jun 30, 2023 | 36.32% |
| Mar 31, 2023 | 121.04% |
| Dec 31, 2022 | -70.77% |
| Sep 30, 2022 | 266.55% |
| Jun 30, 2022 | -98.94% |
| Mar 31, 2022 | -83.24% |
| Dec 31, 2021 | -111.22% |
| Sep 30, 2021 | 156.71% |
| Jun 30, 2021 | 15.75% |
| Mar 31, 2021 | 43.84% |
| Dec 31, 2020 | 17.31% |
| Sep 30, 2020 | -29.12% |
| Jun 30, 2020 | 103.61% |
| Mar 31, 2020 | 93.66% |
| Dec 31, 2019 | -82.58% |
| Sep 30, 2019 | -15.46% |
| Jun 30, 2019 | -30.91% |
| Mar 31, 2019 | 14.23% |
| Dec 31, 2018 | 351.76% |
| Sep 30, 2018 | 98.13% |
| Jun 30, 2018 | 55.43% |
| Mar 31, 2018 | 75.61% |
| Dec 31, 2017 | 125.57% |
| Sep 30, 2017 | 58.10% |
| Jun 30, 2017 | 140.78% |
| Mar 31, 2017 | 279.82% |
| Dec 31, 2016 | 501.79% |
| Sep 30, 2016 | 427.95% |
| Jun 30, 2016 | 286.90% |
| Mar 31, 2016 | 141.58% |
| Dec 31, 2015 | 127.01% |
| Sep 30, 2015 | 78.45% |
| Jun 30, 2015 | 87.71% |
| Mar 31, 2015 | 84.24% |
| Dec 31, 2014 | 68.10% |
| Sep 30, 2014 | 54.73% |
| Jun 30, 2014 | -74.49% |
| Mar 31, 2014 | -81.22% |
| Dec 31, 2013 | -59.40% |
| Sep 30, 2013 | -35.43% |
| Jun 30, 2013 | 1.86% |
| Mar 31, 2013 | -144.16% |
| Dec 31, 2012 | 15.36% |
| Sep 30, 2012 | -13.28% |
| Jun 30, 2012 | -48.21% |
| Mar 31, 2012 | 473.20% |
| Dec 31, 2011 | -91.76% |
| Sep 30, 2011 | -44.31% |
| Jun 30, 2011 | -20.37% |